Uncategorized
Merck, Amgen double down on bad cholesterol to vanquish number 1 killer
Merck, Amgen double down on bad cholesterol to vanquish number 1 killer
New guidelines from two leading medical associations suggest that efforts to reduce bad cholesterol should focus on maintaining low levels of two key lipoproteins. Big pharma is all in, looking to improve on the standard statins to help vanquish America’s number one killer: heart disease. Read More